Search
Descriptor English: Capecitabine
Descriptor Spanish: Capecitabina
Descriptor capecitabina
Scope note: PROFÁRMACO derivado de la desoxicitidina y fluorouracilo que se utiliza como un ANTIMETABOLITO ANTINEOPLÁSICO en el tratamiento del CÁNCER DEL COLON, CÁNCER DE MAMA y CÁNCER GÁSTRICO.
Descriptor Portuguese: Capecitabina
Descriptor French: Capécitabine
Entry term(s): N(4)-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine
Xeloda
Tree number(s): D03.383.742.680.245.500.425
D03.383.742.698.875.404.425
D13.570.230.329.313
D13.570.685.245.500.425
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000069287
Scope note: A deoxycytidine derivative and fluorouracil PRODRUG that is used as an ANTINEOPLASTIC ANTIMETABOLITE in the treatment of COLON CANCER; BREAST CANCER and GASTRIC CANCER.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Antimetabolites, Antineoplastic
Registry Number: 6804DJ8Z9U
Public MeSH Note: 2016; CAPECITABINE was indexed under DEOXYCYTIDINE and FLUOROURACIL 1998-2015
History Note: 2016 (1998)
DeCS ID: 55928
Unique ID: D000069287
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2016/05/27
Capecitabine - Preferred
Concept UI M0287377
Scope note A deoxycytidine derivative and fluorouracil PRODRUG that is used as an ANTINEOPLASTIC ANTIMETABOLITE in the treatment of COLON CANCER; BREAST CANCER and GASTRIC CANCER.
Preferred term Capecitabine
Entry term(s) N(4)-pentyloxycarbonyl-5'-deoxy-5-fluorocytidine
Xeloda - Narrower
Concept UI M0374572
Preferred term Xeloda



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey